Tc-99m标有PSMA-617作为前列腺癌诊断的潜在SPECT放射追踪器:复杂化优化及其体外/体外评估
Kalapaphuk Tachatumvitoon1, Charasphat Preuksarattanawut2, Thititip Tippayamontri3
1Interdisciplinary Program of Biomedical Engineering, Faculty of Engineering, Chulalongkorn University, Bangkok, Thailand.
Bioorganic & medicinal chemistry
|January 4, 2025
概括
一种针对前列腺癌的新型Technetium-99m (Tc-99m) 放射性药物显示出高标签效率和稳定性. 这种标有Tc-99m标记的PSMA-617追踪剂在临床前研究中显示出前列腺癌的优秀选择性.
科学领域:
- 核医学是一种核医学.
- 放射性药物化学 放射性药物化学
- 在瘤学瘤学.
背景情况:
- 技术-99m (Tc-99m) 是用于核成像的广泛使用的放射性核化物,由于其有利于单光子发射计算机断层扫描 (SPECT) 的物理性质.
- 目前前前列腺癌的诊断成像缺乏FDA批准的基于Tc-99m的放射性药物.
- PSMA-617是前列腺癌的流-177 (Lu-177) 放射性核酸疗法的已确立的配体.
研究的目的:
- 开发和评估一种基于Tc-99m的新型放射性药物用于前列腺癌诊断.
- 为了研究TC-99m与PSMA-617的复杂化.
- 评估新的标记Tc-99m的PSMA-617追踪器的稳定性和选择性.
主要方法:
- 用PSMA-617配合Tc-99m复合的配方,使用与酸盐的共同复合.
- 在体外评估放射性药物稳定性在正常盐水和人血清中.
- 使用LNCaP异种移植小鼠模型进行体内研究,以评估瘤向和选择性.
主要成果:
- 使用酸盐联合复杂化,与PSMA-617进行TC-99m复杂化的标记效率超过97%.
- 标记PSMA-617的Tc-99m在各种溶液中超过Tc-99m的一半生命的体外稳定性.
- 在体内证实了新型前列腺癌Tc-99m标记物的高选择性.
结论:
- 一种新的TC-99m标记PSMA-617放射性药物成功开发,具有高标记效率和稳定性.
- 开发的追踪器对前列腺癌具有有希望的高选择性,这表明它对诊断应用的潜力.
- 这种Tc-99m配方扩大了Tc-99m在前列腺癌诊断中的实用性,解决了一个尚未满足的临床需求.
相关概念视频
Positron Emission Tomography
4.0K
Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
4.0K
Imaging Studies II: Positron Emission Tomography and Scintigraphy
81
Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
Fundamental Principles of PET
81


